Indian state unable to obtain Covid-19 shots directly from Moderna

Indian state unable to obtain Covid-19 shots directly from Moderna

Indian state unable to obtain Covid-19 shots directly from Moderna

Moderna is expecting to launch a single-dose COVID-19 vaccine in India next year and is in talks with Cipla among other Indian firms, while another U.S. giant Pfizer is ready to offer 5 crore shots in 2021 itself but it wants significant regulatory relaxations including indemnification, sources said on Tuesday.

USA regulators took about a month to review a similar study from Pfizer/BioNtech, which was authorized for ages 12-15 on May 10. But earlier this month, the USA and Canada authorised another vaccine - the shot made by Pfizer and BioNTech - to be used starting at age 12.

Moderna's clinical trial involved 3,732 adolescents, who were given two shots - of either the vaccine or a placebo.

In the statement, Punjab official Vikas Garg said that the state government had also made approaches regarding the Pfizer, Johnson & Johnson and Sputnik vaccines but has yet to receive any response.

In addition to appearing to be 100 percent effective after two doses, the vaccine was found to be 93 percent effective after one dose. The remaining third received two doses of placebo.

This included against both symptomatic and asymptomatic illness. Chief minister Amarinder Singh said they were told that the companies would, as policy, deal directly with the central government and not state government or private parties. The most common side effects after the second dose were headache, fatigue, body aches and chills.

These include 97,79,304 healthcare workers (HCWs) who have taken the first dose and 67,18,723 HCWs who have taken the second dose, 1,50,79,964 frontline workers (FLWs) who have received the first dose and 83,55,982 FLWs who have taken the second dose, and 1,19,11,759 beneficiaries in the 18-44 year age group who have received the first dose.

Pfizer and BioNTech have been consistently delivering doses even as other vaccine makers have struggled to keep their shipments flowing.

Depending on how quickly Moderna submits its FDA application and how long regulators take to review it, it could mean another option for parents to vaccinate their children before the start of the 2021-22 school year.

Only about three in 10 parents - 29 percent - of children under 18 said they would get their child vaccinated 'right away'.

It also said that the allocation of doses and implementation plan within a country was a decision for the local governments.

Some have criticized the US for vaccinating children - who are less susceptible to serious COVID-19 infections- while more vulnerable adult populations in countries across the world, including India, are yet to be vaccinated.

More than 3.94 million children have tested positive for the virus as of Monday, according to the American Academy of Pediatrics, but only make up 0.1 percent of all deaths.

Related news



[an error occurred while processing the directive]